Back to Search Start Over

Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species-dependent JNK and endothelial nitric oxide synthase activation and overrides imatinib resistance.

Authors :
Chakraborty JB
Mahato SK
Joshi K
Shinde V
Rakshit S
Biswas N
Choudhury Mukherjee I
Mandal L
Ganguly D
Chowdhury AA
Chaudhuri J
Paul K
Pal BC
Vinayagam J
Pal C
Manna A
Jaisankar P
Chaudhuri U
Konar A
Roy S
Bandyopadhyay S
Source :
Cancer science [Cancer Sci] 2012 Jan; Vol. 103 (1), pp. 88-99. Date of Electronic Publication: 2011 Nov 07.
Publication Year :
2012

Abstract

Alcoholic extract of Piper betle (Piper betle L.) leaves was recently found to induce apoptosis of CML cells expressing wild type and mutated Bcr-Abl with imatinib resistance phenotype. Hydroxy-chavicol (HCH), a constituent of the alcoholic extract of Piper betle leaves, was evaluated for anti-CML activity. Here, we report that HCH and its analogues induce killing of primary cells in CML patients and leukemic cell lines expressing wild type and mutated Bcr-Abl, including the T315I mutation, with minimal toxicity to normal human peripheral blood mononuclear cells. HCH causes early but transient increase of mitochondria-derived reactive oxygen species. Reactive oxygen species-dependent persistent activation of JNK leads to an increase in endothelial nitric oxide synthase-mediated nitric oxide generation. This causes loss of mitochondrial membrane potential, release of cytochrome c from mitochondria, cleavage of caspase 9, 3 and poly-adenosine diphosphate-ribose polymerase leading to apoptosis. One HCH analogue was also effective in vivo in SCID mice against grafts expressing the T315I mutation, although to a lesser extent than grafts expressing wild type Bcr-Abl, without showing significant bodyweight loss. Our data describe the role of JNK-dependent endothelial nitric oxide synthase-mediated nitric oxide for anti-CML activity of HCH and this molecule merits further testing in pre-clinical and clinical settings.<br /> (© 2011 Japanese Cancer Association.)

Details

Language :
English
ISSN :
1349-7006
Volume :
103
Issue :
1
Database :
MEDLINE
Journal :
Cancer science
Publication Type :
Academic Journal
Accession number :
21943109
Full Text :
https://doi.org/10.1111/j.1349-7006.2011.02107.x